Aging and Pharmacological Therapy: Prevalence of the Most Used Pharmacological Groups in a Group of Elderly People from the Senior University of Amares (Portugal)
摘要
Aging is a global phenomenon with multiple challenges for health systems, regarding the management of chronic diseases and comorbidities. This scenario leads to the use of different pharmacological groups, necessary for the control of diseases such as hypertension, diabetes, cardiovascular diseases, and neurodegenerative disorders. Is research work aimed to study the prevalence of the most used pharmacological groups in a group of elderly people integrated at the Senior University of Amares (Braga, Portugal) Portugal. The methodology used was quantitative. The group of elderly people integrated at the Senior University of Amares, also participants in a pilot program of health and therapeutic movement and physical exercise for active aging, the project FisioSeniorMoving, they responded to a diverse set of structured and oriented questions for the evaluation of clinical and pharmacological history, after written informed consent. In a group of 23 elderly people of both gender (masculine n = 13; female n = 10) with mean age of 76 years, the most used pharmacological groups are: sedatives n = 5 (21.7%); anxiolytics n = 10 (43.5%); antidepressants n = 1 (4.3%); anti-inflammatories non-steroidal (AINEs) n = 2 (8.7%); corticosteroids n = 1 (4.3%) and analgesics n = 1 (4.3%). It is noted that none of the elderly people are aware of taking anticonvulsants. Other significant pharmacological groups used by the elderly group include medication for control of diabetes mellitus n = 5 (21.7%); for control of hypercholesterolemia n = 11 (47.8%); hypertension arterial n = 16 (69.6%) and anticoagulants n = 3 (13.0%). We highlight the prevalence of use of anxiolytics, sedatives and antidepressants of 69.5%, in this group of the population. The analysis of the results also allows us to infer that 12 (52.2%) of the elderly use three or more different pharmacological groups per day, which may increase the risk of drug interactions. The results show that the pharmacological groups most used by the group participating in the study go against the control of the main diseases of today such as diabetes mellitus, hypertension, cardiovascular diseases, and in a very significant way to mental Health. Aging poses complex challenges to health management, especially regarding the use of pharmacological therapies.